BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2019 10:17:12 AM | Browse: 792 | Download: 1193
 |
Received |
|
2019-04-01 01:57 |
|
Peer-Review Started |
|
2019-04-04 07:26 |
|
To Make the First Decision |
|
2019-05-09 00:30 |
|
Return for Revision |
|
2019-05-09 02:16 |
|
Revised |
|
2019-05-13 00:53 |
|
Second Decision |
|
2019-05-13 11:05 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-05-14 01:27 |
|
Articles in Press |
|
2019-05-14 01:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-05-14 09:49 |
|
Publish the Manuscript Online |
|
2019-05-15 10:17 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Leonardo Pozo, Fatimah Bello, Andres Suarez, Francisco E Ochoa-Martinez, Yamely Mendez, Chelsea H Chang and Salim Surani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Salim Surani, BSc, FACC, FACP, FCCP, MD, Professor, Medical Critical Care Services, Christus Spohn Hospitals-Corpus Christi, 701 Ayers street, Corpus Christi, TX 78404, United States. srsurani@hotmail.com |
| Key Words |
Type 2 diabetes mellitus; Glucagon-like-peptide 1 agonists; Sodium-glucose cotransporter-2 inhibitor; Cardiovascular disease; Major adverse cardiovascular event |
| Core Tip |
Cardiovascular diseases are of significant concern in patients with type 2 diabetes mellitus. Novel therapies offer a new opportunity for cardiovascular risk reduction and add complexity in terms of selecting antihyperglycemic treatment. These pharmacological therapies, however, also have additional considerations. |
| Publish Date |
2019-05-15 10:17 |
| Citation |
Pozo L, Bello F, Suarez A, Ochoa-Martinez FE, Mendez Y, Chang CH, Surani S. Novel pharmacological therapy in type 2 diabetes mellitus with established cardiovascular disease: Current evidence. World J Diabetes 2019; 10(5): 291-303 |
| URL |
https://www.wjgnet.com/1948-9358/full/v10/i5/291.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v10.i5.291 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
